|
Volumn 120, Issue 10, 2013, Pages 1168-1170
|
Does screening for pre-eclampsia make sense?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
PLACENTAL GROWTH FACTOR;
BLOOD PRESSURE MEASUREMENT;
CLINICAL PRACTICE;
COST CONTROL;
DIAGNOSTIC TEST;
HEALTH CARE SYSTEM;
HYPERTENSION;
LOW RISK POPULATION;
MATERNAL MORBIDITY;
MATERNAL MORTALITY;
NOTE;
PREECLAMPSIA;
PRENATAL CARE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK ASSESSMENT;
SCREENING TEST;
TREATMENT DURATION;
URINALYSIS;
COST-BENEFIT ANALYSIS;
FEMALE;
GREAT BRITAIN;
GUIDELINES AS TOPIC;
HUMANS;
MASS SCREENING;
PRE-ECLAMPSIA;
PREGNANCY;
|
EID: 84882240890
PISSN: 14700328
EISSN: 14710528
Source Type: Journal
DOI: 10.1111/1471-0528.12309 Document Type: Note |
Times cited : (12)
|
References (7)
|